Journal of Young Pharmacists logo
Submit
Journal of Young PharmacistsACADEMIC PUBLISHING
Article

Sorafenib Induced Hand and Foot Syndrome

1, 2★, 1★ Corresponding author

  1. 1Pharm D intern, Department of Pharmacy Practice, Amrita School of Pharmacy, Kochi 682041, Amrita University, INDIA.
  2. 2Assistant Professor, Department of Pharmacy Practice, Amrita School of Pharmacy, Kochi 682041, Amrita University, INDIA.

CORRESPONDENCE

Remya Reghu

Assistant Professor, Department of Pharmacy Practice, Amrita School of Pharmacy, Kochi 682041, Amrita University, INDIA.

remyareghu@aims.amrita.edu

Received: 06-06-2017; Revised: 21-07-2017; Accepted: 31-08-2017.

Volume 10, Issue 1 · pp. 129-130 · 2018 · DOI: 10.5530/jyp.2018.10.29

ABSTRACT

Sorafenib a multikinase inhibitor has been approved by the FDA for the treatment of thyroid, hepatocellular and renal cell carcinoma. Hand-foot syndrome / palmar – plantar erythrodysesthesia causes redness, swelling and pain on the palms of the hands and / or the soles of the feet. Sometimes blisters also appear. Here, we report a post right hepatectomy hepatocellular carcinoma patient who developed hand and foot syndrome after a dose with sorafenib.

KEYWORDS

Open in new tab

REFERENCES

As published

Showing references and in-text citations exactly as published.

    Cite this article

    SELECT FORMAT

    Susan, D., M, M., & Reghu, R. (2018). Sorafenib Induced Hand and Foot Syndrome. Journal of Young Pharmacists, 10(1), 129-130. https://doi.org/10.5530/jyp.2018.10.29

    Copyright and licence

    © 2018 Author(s)

    This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms. CC BY-NC-SA 4.0